PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.51%
Revenue growth above 1.5x MDB's 1.93%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
8.67%
Positive gross profit growth while MDB is negative. John Neff would see a clear operational edge over the competitor.
-26.39%
Negative EBIT growth while MDB is at 16.42%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-26.39%
Negative operating income growth while MDB is at 6.03%. Joel Greenblatt would press for urgent turnaround measures.
-26.60%
Negative net income growth while MDB stands at 15.76%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-30.00%
Negative EPS growth while MDB is at 17.20%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-30.00%
Negative diluted EPS growth while MDB is at 17.20%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.94%
Share count expansion well above MDB's 0.94%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.94%
Diluted share count expanding well above MDB's 0.94%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
339.06%
OCF growth above 1.5x MDB's 107.68%. David Dodd would confirm a clear edge in underlying cash generation.
176.67%
FCF growth above 1.5x MDB's 111.08%. David Dodd would verify if the firm’s strategic investments yield superior returns.
2.99%
10Y revenue/share CAGR under 50% of MDB's 182.94%. Michael Burry would suspect a lasting competitive disadvantage.
2.99%
5Y revenue/share CAGR under 50% of MDB's 447.94%. Michael Burry would suspect a significant competitive gap or product weakness.
2.99%
3Y revenue/share CAGR under 50% of MDB's 132.13%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
112.47%
10Y OCF/share CAGR at 50-75% of MDB's 186.66%. Martin Whitman might fear a structural deficiency in operational efficiency.
112.47%
Below 50% of MDB's 578.94%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
112.47%
3Y OCF/share CAGR under 50% of MDB's 850.91%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
21.93%
Below 50% of MDB's 58.40%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
21.93%
Positive 5Y CAGR while MDB is negative. John Neff might view this as a strong mid-term relative advantage.
21.93%
3Y net income/share CAGR 1.25-1.5x MDB's 17.43%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
-1.99%
Negative equity/share CAGR over 10 years while MDB stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-1.99%
Negative 5Y equity/share growth while MDB is at 229.58%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-1.99%
Negative 3Y equity/share growth while MDB is at 932.61%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.52%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-20.13%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.14%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.56%
We have a declining book value while MDB shows 6.16%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-14.27%
We’re deleveraging while MDB stands at 0.01%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
10.55%
R&D growth drastically higher vs. MDB's 5.34%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
15.51%
We expand SG&A while MDB cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.